Investors pump another $8.8M into KC medical device startup, bringing funding total to $20M+
March 31, 2020 | Startland News Staff
A Fairway-based medical device company is getting to the heart of its entrepreneurial journey, securing a fresh $8.8 million in Series A financing, Dr. Nicholas Franano announced Tuesday.
The additional influx to Artio — rebranded from “Metactive” earlier this winter — brings the startup’s total capital raised to more than $20 million. The company has spent years developing groundbreaking, best-in-class products for the peripheral vascular and neurovascular markets, said Franano, founder, president and CEO of Artio.
“We appreciate the strong support from our new and existing investors,” he said. “Our team is looking forward to making our innovative products available to physicians and patients.”
Click here to see why Artio/Metactive was named one of Startland News’ Kansas City Startups to Watch in 2019.
Funds from the latest round are expected to help Artio obtain 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market its Solus Gold Embolization Device in the United States.
Solus Gold Embolization Device
The Solus Gold is the first metal implant to provide a solid barrier to blood flow, and is developed for peripheral vascular embolization — a minimally invasive procedure that blocks or reduces blood flow in blood vessels for patients experiencing life-threatening bleeding and other serious medical conditions.
The combination of a low-profile, flexible delivery system and a detachable gold metal implant is designed for passage through tortuous blood vessels, precision placement, and immediate vessel occlusion after placement of a single device, according to the company.
Franano’s team also has revealed two other next-gen embolization products, the Solus Flex device and Aneura system.
Click here to learn more about these peripheral vascular solutions.
“Artio is developing a strong portfolio of disruptive, next-generation peripheral vascular and neurovascular embolization products, and we were thrilled to help lead the latest round of funding,” said Nathaniel Hagedorn, founder and CEO of Northpoint Development. “I have been incredibly fortunate to have so many people help me build my business and am happy to ‘pay it forward’ to a fellow entrepreneur with a clear vision and accomplished team.”
Featured Business
2020 Startups to Watch
stats here
Related Posts on Startland News
CB Insights calls KCRise most active VC in Kansas; Fund credits work of small team, innovative portfolio startups
Kansans don’t fear hard work, said Darcy Howe. An investment in such a mindset has come with big returns for the KCRise Fund, newly proclaimed the most active venture capital fund in the Sunflower State, according to CB Insights. “Perhaps overused but Margaret Mead’s quote, ‘Never doubt that a small group of thoughtful, committed citizens…
Overland Park-based CAPS education network launching cross-cultural program in India
The Center for Advanced Professional Studies’ (CAPS) first international affiliate program in India has the potential to break down geographic barriers to provide students with exposure to real workplace experiences on a global stage, said Corey Mohn. “I think [the American School of Bombay] is really the perfect partner to get started with,” said Mohn,…
New $750K investment round for Lula comes with partner in apartment management
Closing a $750,000 seed round is even more impactful with a strategic partner like Worcester Investments, said Lula founder Bo Lais. “We did have three other private investors, that were minority investors with two of them local, but it’s [become] more than just investment with [with Worcester],” said Lais, CEO of the Overland Park-based home…
Chronic Cow uses big data to attack pain: ‘I can still live a good life,’ founder with MS says
Half of all Americans have a chronic illness, said former TeraCrunch co-founder Dr. Kevin Payne. That somber reality, paired with uninvolved physicians, makes quality of life difficult for patients and the focus of Payne’s new venture, Chronic Cow, he said. “From a medical perspective, all I can do as a patient is what my physicians…